William Blair analyst Sami Corwin has maintained their bullish stance on ZVRA stock, giving a Buy rating today. Sami Corwin’s rating is ...

CAMP4 Therapeutics raises $75 million in IPO, advances RNA therapies for rare diseases, and partners with BioMarin. Analysts ...

Leerink initiated coverage of Camp4 Therapeutics (CAMP) with an Outperform rating and $17 price target The firm believes CMP-CPS-001, the lead ...

Blood urea nitrogen (BUN) is a blood test performed as a marker of kidney function. It is part of the basic or comprehensive metabolic panel done for health screening. It is also used to monitor the ...

The cryptocurrency world is witnessing a seismic shift as bitcoin, the pioneer in digital assets, appears to be breaking free from its long-established four-year cycle in favor of a so-called ...

The stock market's overall movements can be described as a repeating cycle that usually has four identifiable stages to it. Understanding the market cycle can help investors make more informed ...

Researchers will aim to target developing therapies for urea cycle disorders, which affect approximately one in every 35,000 children, according to the Penn Medicine announcement. Central to the ...

The water cycle is the vital Earth process that moves freshwater and moisture around the planet, and for the first time in human history, that system is breaking down. A new report from the Global ...